|
|
|
|
-O-(3-thio)triphosphate
Binding: Agonist Potencies and the Influence of Sodium Chloride on
Intrinsic Activity
Glaxo Institute of Applied Pharmacology, Department of
Pharmacology, University of Cambridge, Cambridge, CB2 1QJ, UK
We studied the activation of the human somatostatin5
receptor recombinantly expressed in CHO-K1 cells by using some newly available agonists and antagonists. Somatostatin-28 bound to this receptor with a higher affinity than somatostatin-14 and was more potent in increasing
[35S]guanosine-5
-O-(3-thio)triphosphate
([35S]GTP
S) binding. Somatostatin-14-induced
[35S]GTP
S binding to membranes from this cell line was
decreased in a concentration-related manner by increasing
concentrations of GDP and sodium chloride. At 50 mM (low)
sodium, agonist EC50 values for stimulating
[35S]GTP
S binding were lower than those at 150 mM (high) sodium and were closer to their respective
affinity estimates (dissociation equilibrium constants) for binding to
the receptor in the absence of sodium. Both agonist binding to the high
affinity state of the receptor and agonist-induced
[35S]GTP
S binding were abolished by pertussis toxin
pretreatment. The putative somatostatin5 receptor-selective
ligand L-362,855, unlike somatostatin-14 and somatostatin-28, showed
differential intrinsic activity for stimulation of
[35S]GTP
S binding, behaving as a partial agonist in
high sodium and a full agonist in low sodium. In contrast, BIM-23056
did not behave as an agonist under any conditions studied but was able to antagonize somatostatin-14-induced [35S]GTP
S
binding. We conclude that measurement of [35S]GTP
S
binding mediated by somatostatin receptor activation in the presence of
different concentrations of sodium chloride provides a useful
functional assay for assessing the relative agonist efficacies of novel
ligands identified from radioligand binding studies.
This article has been cited by other articles:
![]() |
M. Engstrom, J.-M. Savola, and S. Wurster Differential Efficacies of Somatostatin Receptor Agonists for G-Protein Activation and Desensitization of Somatostatin Receptor Subtype 4-Mediated Responses J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 1262 - 1268. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. W. Fitzgerald, J. P. Patterson, D. S. Conklin, R. Horlick, and B. L. Largent Pharmacological and Biochemical Characterization of a Recombinant Human Galanin GALR1 Receptor: Agonist Character of Chimeric Galanin Peptides J. Pharmacol. Exp. Ther., November 1, 1998; 287(2): 448 - 456. [Abstract] [Full Text] |
||||
![]() |
N. Fukushima, Y. Kimura, and J. Chun A single receptor encoded by vzg-1/lpA1/edg-2 couples to G proteins and mediates multiple cellular responses to lysophosphatidic acid PNAS, May 26, 1998; 95(11): 6151 - 6156. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Dairaghi, E. R. Oldham, K. B. Bacon, and T. J. Schall Chemokine Receptor CCR3 Function Is Highly Dependent on Local pH and Ionic Strength J. Biol. Chem., November 7, 1997; 272(45): 28206 - 28209. [Abstract] [Full Text] [PDF] |
||||